Saturday 17 October 2026 Export SLN’s income statement to Excel — free account

Silence Therapeutics PLC Sponsored ADR

Silence Therapeutics PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $559,000.00, down 98.7% from fiscal 2024. In the quarter to June 2026, revenue grew 197.2%, EPS grew 54.4% and free cash flow grew 107.0%, each against the same quarter a year earlier.

8.68 0.67 −7.17%

Follow SLN

Alert me

Market cap: $581.1M
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: 2/9
Altman Z: −4.82
Beneish M: 45.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	1	3	—
ROE Full definition →		(65.53%)	(90.27%)	(236.94%)	(90.41%)
ROA Full definition →		(35.16%)	(53.05%)	(49.96%)	(44.14%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(54.74%)	(83.11%)	(80.01%)	(72.33%)
Average Days of Receivables Full definition →		313.42	14,369.51	9,664.89	0.00
Free Cash Flow per Share Full definition →		(1.54)	(1.32)	(1.39)	(0.89)
Free Cash Flow Full definition →		(72.58)	(62.33)	(65.56)	(42.26)
Capital Expenditures Full definition →		(0.12)	(0.05)	—	—
Other line items
Cash ROIC Full definition →		(41.18%)	(42.26%)	(54.86%)	(38.24%)
Accounts Receivable Turnover Full definition →		1.18	0.02	0.04	0.00
Accounts Payable Turnover Full definition →		0.13	0.01	0.01	0.00
Inventory Turnover Full definition →		0.00	0.00	0.00	—
Average Days of Payables Full definition →		2,767.71	22,674.14	21,999.74	0.00
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	—
Tax Rate Full definition →		0.01	0.00	0.00	0.01
Research and Development Expense of Revenue Full definition →		313.90%	12,120.39%	6,682.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		93.51%	3,997.14%	2,584.74%	0.00%
Share Based Compensation of Revenue Full definition →		47.00%	1,444.36%	832.06%	0.00%
Operating CF/Net income Full definition →		1.12	0.70	0.87	0.70
Depreciation/Fixed assets Full definition →		0.35	0.35	0.37	0.36
Capex/Depreciation Full definition →		(0.20)	(0.10)	0.00	0.00
Revenue per Share Full definition →		0.55	0.01	0.02	0.00
Operating CF per Share Full definition →		(1.53)	(1.32)	(1.39)	(0.89)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.10	0.00	—

Show all line items

Columns are period end dates

Stockrow Weekly